Primit Parikh - 17 Nov 2022 Form 4 Insider Report for Transphorm, Inc. (TGAN)

Role
President and COO
Signature
/s/ Cameron McAulay, Attorney-in-Fact
Issuer symbol
TGAN
Transactions as of
17 Nov 2022
Transactions value $
-$50,652
Form type
4
Filing time
21 Nov 2022, 15:16:51 UTC
Previous filing
31 Aug 2022
Next filing
28 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TGAN Common Stock Sale -$50,651 -8,927 -3.62% $5.67 237,558 17 Nov 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported shares were sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units.
F2 This sale price represents the weighted average sale price of the shares sold ranging from $5.45 to $5.98 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.